EE9900601A - Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid - Google Patents

Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid

Info

Publication number
EE9900601A
EE9900601A EEP199900601A EEP9900601A EE9900601A EE 9900601 A EE9900601 A EE 9900601A EE P199900601 A EEP199900601 A EE P199900601A EE P9900601 A EEP9900601 A EE P9900601A EE 9900601 A EE9900601 A EE 9900601A
Authority
EE
Estonia
Prior art keywords
tocopherol
inhaled
powders stabilized
proliposome powders
proliposome
Prior art date
Application number
EEP199900601A
Other languages
English (en)
Estonian (et)
Inventor
Bystr�m Katarina
Nilsson Per-Gunnar
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900601A publication Critical patent/EE9900601A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP199900601A 1997-06-27 1998-06-08 Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid EE9900601A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (en) 1997-06-27 1998-06-08 Proliposome powders for inhalation stabilised by tocopherol

Publications (1)

Publication Number Publication Date
EE9900601A true EE9900601A (et) 2000-08-15

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900601A EE9900601A (et) 1997-06-27 1998-06-08 Tokoferooliga stabiliseeritud inhaleeritavad proliposoomipulbrid

Country Status (18)

Country Link
EP (1) EP1001749A1 (is)
JP (1) JP2002510311A (is)
KR (1) KR20010014163A (is)
CN (1) CN1260713A (is)
AU (1) AU729100B2 (is)
BR (1) BR9810280A (is)
CA (1) CA2295028A1 (is)
EE (1) EE9900601A (is)
HU (1) HUP0003207A3 (is)
ID (1) ID23192A (is)
IL (1) IL133478A0 (is)
IS (1) IS5304A (is)
NO (1) NO996439L (is)
NZ (1) NZ501672A (is)
PL (1) PL337723A1 (is)
SK (1) SK184899A3 (is)
TR (1) TR199903271T2 (is)
WO (1) WO1999000111A1 (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138310A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138313A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1138311A1 (de) * 2000-03-28 2001-10-04 Primacare S.A. Pro-liposomen
EP1888033B1 (en) * 2005-06-09 2014-02-19 Meda AB Method and composition for treating inflammatory disorders
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
CN105188415A (zh) * 2013-05-06 2015-12-23 帝斯曼知识产权资产管理有限公司 粉末状维生素e制剂
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3824296B1 (en) 2018-07-20 2026-04-01 Lipocine Inc. Oral pharmaceutical composition comprising testosterone tridecanoate and/or testosterone dodecanoate for treating liver diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0527940A1 (en) * 1990-05-08 1993-02-24 Liposome Technology, Inc. Direct spray-dried drug/lipid powder composition
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق

Also Published As

Publication number Publication date
HUP0003207A3 (en) 2001-03-28
AU729100B2 (en) 2001-01-25
HUP0003207A2 (hu) 2001-02-28
NZ501672A (en) 2001-06-29
SK184899A3 (en) 2000-05-16
KR20010014163A (ko) 2001-02-26
BR9810280A (pt) 2000-09-12
NO996439L (no) 2000-02-28
CN1260713A (zh) 2000-07-19
IS5304A (is) 1999-12-15
TR199903271T2 (en) 2000-08-21
AU7945698A (en) 1999-01-19
PL337723A1 (en) 2000-08-28
NO996439D0 (no) 1999-12-23
CA2295028A1 (en) 1999-01-07
JP2002510311A (ja) 2002-04-02
WO1999000111A1 (en) 1999-01-07
EP1001749A1 (en) 2000-05-24
ID23192A (id) 2000-03-23
IL133478A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
EE9700134A (et) Proliposoomi pulbrid inhaleerimiseks
EE200400122A (et) Pulberinhalaator
NO990272L (no) Pulver-inhalator
DE69708327D1 (de) Pulverinhalator
FI942196A7 (fi) Jauheinhalaattori
ID24472A (id) Pembuatan aglomerat bubuk
PL340284A1 (en) Modified polypeptides dependent on vitamin k
IS5487A (is) Innúðatæki
ID18427A (id) Pengkabut serbuk
AU135548S (en) Inhaler
AU135120S (en) Inhaler
DE69838271D1 (de) Verbesserte Atemschutzmaske
AU135340S (en) An inhaler
FI964595A7 (fi) Pulveri-inhalaattori
NO996439D0 (no) Proliposompulvere for inhalering stabilisert med tokoferol
FR2763507B1 (fr) Inhalateur
FI955441L (fi) Jauheinhalaattori
DE69824327D1 (de) Inhalationsgerät
NO20003182L (no) FremgangsmÕte for inhalering av pulverstoffer
ID19844A (id) Komponen tumbukan
SE9703829D0 (sv) Powder inhaleri
DE59807895D1 (de) Pulverklarlack
FI964489L (fi) Jauheinhalaattori
SE9700945D0 (sv) Powder inhaler VII
SE9603353D0 (sv) Powder inhaler III